General description
Delamanid is an anti-mycobacterial agent used in combination therapy treatment protocols for multi-drug resistant tuberculosis (MDR-TB).
INN
Delamanid
Medicine type
Chemical agent
EML status history
First added in 2015
(TRS
994)
for
Multi-drug resistant tuberculous Mycobacterium
Therapeutic equivalent for
Wikipedia
Recommendations
Section
Antituberculosis medicines
- Oral > Solid: 50 mg tablet
Indications